glp-1 shortage Government declares 'national shortage' of receptor agonists for type 2 diabetes until 2024 The GLP-1 shortage is real.

Long-term human studies beyond 12 weeks exist for retinoids in a way they don't yet for copper peptides

11.8% average weight loss as monotherapy in Phase 3 trialsclinically significant and comparable to first-generation GLP-1 medications

Growth of glutathione Market research firm Stratview Research projects that the global glutathione market will grow at a compound annual growth rate of over 7% during the 2022-2028 forecast period to surpass $576 million, with applications across pharmaceutical, cosmetic, nutraceutical and food segments

Rapid-acting antidepressant-like effects of acetyl-l-carnitine mediated by PI3K/AKT/BDNF/VGF signaling pathway in mice